Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) CEO Interview with James F. Oliviero discussing clinical progress in company’s pipeline of cancer drugs, addressing multi-billion dollar markets. The company’s lead […]
TriStar Gold (TSX. V: TSG) CEO Interview with Nick Appleyard, discussing the company’s “Castelo de Sonhos” gold project in Brazil. The project currently has a resource of 2 million ounces of gold. Nick explains how […]
Hubilu Venture Corporation (OTC: HBUV) Interview with David Behrend, CEO, discussing company’s student housing business, with a specific focus on serving Los Angeles and USC student market.
AmeraMex International (OTC: AMMX) Interview with CEO Lee Hamre, discussing the company’s growing revenues and profits in the heavy equipment sales and rental business. The company’s specialty is sales […]
Polydex Pharmaceuticals Ltd. (OTC: POLXF) CEO Interview with George Usher, discussing the company’s specialty chemical business which supplies dextran products to pharmaceutical manufacturers worldwide. Topics discussed include, overview of global market for dextran, […]
Generex Biotechnology Corp. (OTC: GNBT) Interview with CEO Joe Moscato. Joe shares an update on the continued transformation of Generex into a next-generation integrated pharmaceutical healthcare business, through […]
Lomiko Metals (TSX.V: LMR) (OTC: LMRMF) Interview with Paul Gill, CEO. Paul shares an update on Lomiko’s graphite exploration projects in Quebec, as well as the company’s venture investments […]
NightFood Holdings, Inc. (OTC: NGTF) Interview with Sean Folkson, CEO. Sean explains how the company is planning to carve out a niche, within the $100 billion snack market, […]
Cobalt27 Capital Corp. (TSX.V: KBLT) (OTC: CBLLF) interview with Anthony Milewski, Chairman & CEO. Cobalt is a key ingredient in electric vehicle, and energy storage batteries. In […]
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody therapy for HIV and cancer. The company is at a […]
Hexo Corp. (TSE: HEXO) CEO Interview with Sebastien St-Louis. Sebastien explains what is driving Hexo’s explosive revenue growth in the cannabis sector, and his vision for […]
Trendlines Group, Ltd. (OTC: TRNLY) (Singapore: 42T), interview with co-CEO/Chairman Steve Rhodes, discussing the company’s investment strategy in early-stage medical and agricultural innovation companies in Israel and Singapore. Since […]
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) interview with CEO, Chaim Lebovits, discussing the company’s advancements in developing stem cell therapies to treat neurodegenerative diseases. The company’s pipeline includes a lead indication for ALS- Amyotrophic Lateral […]
The Yield Growth Corp. (CSE: BOSS) interview with CEO Penny Green. In the company’s first interview since going public December 14, 2018, Penny Green explain’s the company’s business […]
Pluristem Therapeutics, Inc. (NASDAQ: PSTI), interview with co-CEO Yaky Yanay. Yaky explains Pluristem’s regenerative medicine technologies, which use placenta-derived cell products, and address multi-billion health markets. Pluristem has 3 […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
